Logo

Public Feeds

Public speeches should be public

Politicians, athletes, journalists, NGOs, companies... They all use corporation-owned social networks to communicate with us. Citizens shouldn't have to hand over their data to companies to read content published by public entities. Public Feeds changes that by making posts of popular accounts freely available. Read more.

Immutep

Immutep

Immutep Ltd (formerly Prima Biomed) is a biotechnology company working primarily in the field of cancer immunotherapy using the LAG3 immune control mechanism. The company was originally built on CVac, a therapeutic cancer vaccine. In late 2014 the privately held French immunotherapy company Immutep SA was purchased by Prima Biotech. More on Wikipedia